David Campbell, MD
Pulmonary Disease · Baton Rouge, LANPI 1134562432
Payments from drug & device makers
Across 67 payments — averaging $19.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$233
- Organogenesis Inc.$157
- Astellas Pharma US Inc$126
- Boehringer Ingelheim$112
- Mallinckrodt Enterprises LLC$59
- Regeneron Healthcare Solutions, Inc.$57
- plus $576 from 19 others
What the payments were for
- Food & beverage$1,319100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 15 | $233 |
| Organogenesis Inc. | 7 | $157 |
| Astellas Pharma US Inc | 6 | $126 |
| Boehringer Ingelheim | 5 | $112 |
| Mallinckrodt Enterprises LLC | 2 | $59 |
| Regeneron Healthcare Solutions, Inc. | 2 | $57 |
| Advanced Respiratory, Inc | 2 | $53 |
| Paratek Pharmaceuticals, Inc. | 3 | $51 |
| Mallinckrodt Hospital Products Inc. | 2 | $49 |
| Mylan Specialty L.p. | 2 | $48 |
| Edwards Lifesciences | 1 | $41 |
| AstraZeneca | 3 | $40 |
| UCB, Inc. | 2 | $34 |
| Chiesi USA, Inc. | 2 | $32 |
| La Jolla Pharmaceutical Company | 2 | $31 |
| E.r. Squibb & Sons, L.L.C. | 2 | $29 |
| Biogen | 1 | $26 |
| Abbott | 1 | $25 |
| Electromed, Inc. | 1 | $25 |
| Novartis | 1 | $18 |
| United Therapeutics Corporation | 1 | $18 |
| Merck | 1 | $17 |
| Portola Pharmaceuticals, LLC | 1 | $16 |
| AbbVie | 1 | $13 |
| Cumberland Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$1,319 in reported general payments places this provider in the 35th percentile of 189 pulmonary disease providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Baton Rouge
- Hollis O NealBaton Rouge$682K
- Alexander MulamulaBaton Rouge$266K
- Robert HinkleBaton Rouge$19K
- Tarek AbdallahBaton Rouge$12K
- Brad VincentBaton Rouge$12K
- David GreenShreveport$2M
- Joseph LaskyNew Orleans$1.9M
- Leonardo SeoaneNew Orleans$1.6M
- Ross KlingsbergNew Orleans$1.2M
- Juzar AliNew Orleans$775K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.